Pharmacogenomics and the challenge of health disparities.

Abstract excerpt

This paper examines emerging technologies and recent research on population differences in pharmacogenomics and the perspectives of scientists, community advocates, policymakers, and social critics on the use of race as a proxy for genetic variation. The discussion focuses on how recent developments in genomic science impact social understandings of racial difference and the public health goal to eliminate...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Design
• Share to Genetic Variation
• Share to Healthcare Disparities